Posted in | News | Nanomaterials

Selah to Present During Nanotechnology Session at 2008 ISPE Annual Meeting

Selah Technologies, an advanced materials manufacturer, announced today that the company has been invited to be a guest speaker at the upcoming 2008 ISPE Annual Meeting. At the ISPE Annual Meeting, pharmaceutical manufacturing industry professionals from around the world will gather to share experiences and gain insights affecting industry change. The upcoming annual meeting will be held from October 26-29, 2008, in Boca Raton, FL.

“Selah is honored to be an invited guest speaker at the upcoming 2008 ISPE Annual Meeting. This presentation will allow Selah to highlight public partnering opportunities available to nanomaterial innovators who understand the need for transparent product stewardship in the pursuit of market opportunities in the healthcare field, especially with respect to the pharmaceutical and biologics industries. Moreover, we will be able to share our story with industry leaders to better position Selah for our upcoming Selah Dots™ product launch,” said Michael Bolick, President and CEO for Selah.

Selah Technologies obtained a worldwide exclusive license in 2006 from Clemson University to develop and commercialize two nanotechnologies, branded Selah Dots™ and Selah Tubes™. Selah Dots™ are patent-pending carbon based nanoparticles that can be used for various applications, including life sciences, solar cells and anti-counterfeiting, among others. Selah Tubes™, enriched carbon nanotubes protected under US Patent No. 7,374,685, have a number of applications due to their impressive electrical and thermal conductivity properties.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.